Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$32.9 - $47.0 $1.94 Million - $2.78 Million
-59,094 Reduced 67.4%
28,588 $949,000
Q1 2024

May 15, 2024

BUY
$41.76 - $74.73 $1.36 Million - $2.43 Million
32,462 Added 58.79%
87,682 $4.2 Million
Q4 2023

Feb 14, 2024

SELL
$58.16 - $75.44 $565,082 - $732,975
-9,716 Reduced 14.96%
55,220 $4.07 Million
Q3 2023

Nov 14, 2023

BUY
$70.9 - $88.63 $4.35 Million - $5.44 Million
61,339 Added 1705.28%
64,936 $4.74 Million
Q2 2023

Aug 14, 2023

SELL
$81.09 - $94.16 $654,639 - $760,153
-8,073 Reduced 69.18%
3,597 $298,000
Q1 2023

May 15, 2023

BUY
$82.98 - $91.46 $968,376 - $1.07 Million
11,670 New
11,670 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$69.86 - $107.63 $1.28 Million - $1.98 Million
-18,390 Reduced 44.7%
22,748 $1.63 Million
Q2 2022

Aug 15, 2022

BUY
$89.06 - $117.64 $3.66 Million - $4.84 Million
41,138 New
41,138 $4 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.51B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.